Gene · 3838
Papers1,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic significance and immune landscape of a cell cycle progression-related risk model in bladder cancer. | Discov Oncol | 2024 | 38735911 | PubTator, text mining | PubMed |
| Integrated grade-wise profiling analysis reveals potential plasma miR-373-3p as prognostic indicator in Prostate Cancer & its target KPNA2. | Noncoding RNA Res | 2024 | 38699204 | PubTator, text mining | PubMed |
| Karyopherin α2 is a maternal effect gene required for early embryonic development and female fertility in mice. | FASEB J | 2024 | 38656660 | PubTator, text mining | PubMed |
| Preparation of hepatocellular carcinoma mRNA vaccines based on potential tumor targets and immunophenotypes. | Transl Cancer Res | 2024 | 38410201 | PubTator, text mining | PubMed |
| Silencing KPNA2 Promotes Ferroptosis in Laryngeal Cancer by Activating the FoxO Signaling Pathway. | Biochem Genet | 2024 | 38379037 | PubTator, text mining | PubMed |
| Quantifying Landscape-Flux via Single-Cell Transcriptomics Uncovers the Underlying Mechanism of Cell Cycle. | Adv Sci (Weinh) | 2024 | 38353329 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma. | Medicine (Baltimore) | 2024 | 38277541 | PubTator, text mining | PubMed |
| Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. | Int J Mol Sci | 2024 | 38256049 | PubTator, text mining | PubMed |
| Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD. | Mol Neurodegener | 2024 | 38254150 | PubTator, text mining | PubMed |
| Establishment and Validation of a Four-stress Granule-related Gene Signature in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2024 | 38250470 | PubTator, text mining | PubMed |
Unraveling the underlying pathogenic factors driving nonalcoholic steatohepatitis and hepatocellular carcinoma: an in-depth analysis of prognostically relevant gene signatures in hepatocellular carcinoma. | J Transl Med | 2024 | 38238845 | PubTator, text mining | PubMed |
| Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization. | Proc Natl Acad Sci U S A | 2024 | 38236733 | PubTator, text mining | PubMed |
| Hsa_circular RNA_0045474 Facilitates Osteoarthritis Via Modulating microRNA-485-3p and Augmenting Transcription Factor 4. | Mol Biotechnol | 2024 | 38206529 | PubTator, text mining | PubMed |
| Genetics of sleep medication purchases suggests causality from sleep problems to psychiatric traits. | Sleep | 2024 | 37982563 | PubTator, text mining | PubMed |
| Hsa_Circ_0000021 Sponges miR-3940-3p/KPNA2 Expression to Promote Cervical Cancer Progression. | Curr Mol Pharmacol | 2024 | 36799424 | PubTator, text mining | PubMed |
| Withaferin A alleviates inflammation and joint injury in arthritic rats via elevating microRNA-1297 to target karyopherin alpha2. | J Physiol Pharmacol | 2023 | 38345447 | PubTator, text mining | PubMed |
| Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system. | Front Immunol | 2023 | 38283360 | PubTator, text mining | PubMed |
| Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment. | Pharmaceutics | 2023 | 38258070 | PubTator, text mining | PubMed |
| Viral Targeting of Importin Alpha-Mediated Nuclear Import to Block Innate Immunity. | Cells | 2023 | 38201275 | PubTator, text mining | PubMed |
| Regulation of m6A Methylome in Cancer: Mechanisms, Implications, and Therapeutic Strategies. | Cells | 2023 | 38201270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3838/papers?page=7